![]() |
Volumn 26, Issue 7, 2008, Pages 729-732
|
Poised to branch out
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATI 001;
CISPLATIN;
CONTRAST MEDIUM;
DENDRIMER;
DOXORUBICIN;
FOLATE RECEPTOR;
GADOMER 24;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LYSINE;
METHOTREXATE;
MICROBICIDE;
NANOMATERIAL;
NAPHTHACENE DERIVATIVE;
PLACEBO;
POLYAMIDOAMINE;
PRIOSTAR;
VIVAGEL;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ACUTE CORONARY SYNDROME;
CLINICAL TRIAL;
DRUG BINDING;
DRUG COST;
DRUG FORMULARY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
DRUG SYNTHESIS;
FOOD AND DRUG ADMINISTRATION;
GENE TARGETING;
HEAD AND NECK CANCER;
HERPES SIMPLEX;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LUNG CANCER;
MEDICAL INSTRUMENTATION;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
NONHUMAN;
PRIORITY JOURNAL;
PROPHYLAXIS;
PSORIASIS;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SKIN CANCER;
VAGINA DISCHARGE;
VAGINAL PRURITUS;
VIRUS TRANSMISSION;
WOUND HEALING;
DENDRIMERS;
DRUG DESIGN;
INTERNATIONALITY;
NANOMEDICINE;
NANOPARTICLES;
|
EID: 46949094765
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0708-729 Document Type: Short Survey |
Times cited : (14)
|
References (6)
|